adjusted net income for the full year was a record $ 132 million , up 11 % from last year .
specialty product net sales were $ 19.6 million for the quarter , a 6 % increase versus the prior year .
1,4 - dioxane is a minor by - product generated in the manufacture of ether sulfate surfactants which are key ingredients in consumer products .
sales volume was down 1 % between quarters and operating income improved 2 % .
tier 2 and tier 3 customers continue to be the center of our strategy .
this project is the driver of our increased capex forecast for 2021 of $ 150 million to $ 170 million .
sales volume increased 8 % , mostly due to higher demand for products sold into the consumer product end markets , driven by increased amount for cleaning , disinfection and personal wash product due to covid - 19 .
the acquired business has global sales of approximately $ 100 million per year .
selling prices declined 8 % and foreign currency translation positively impacted net sales by 1 % .
we remain optimistic about future opportunities in this business as oil prices have recovered through the $ 60 per barrel levels .
we had negative net debt at year - end as our cash balance of $ 350 million exceeded total debt of $ 199 million .
the company expects the multiple on a post - synergy basis to be between 6.5 and 7.5 times .
stepan has paid higher dividends for 53 consecutive years .
the acquisition cost was $ 165 million plus working capital and is expected to be slightly accretive to stepan 's earnings per share and ebitda margins in 2021 .
lower mexico results were due to a high base period with insurance payment in december 2019 , although mexico volume was up 31 % .
board of directors declared a quarterly cash dividend on stepan 's common stock of $ 0.305 per share payable on march 15 , 2021 .
